Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
Formula 12 Thyroid
No one logged in.

Protocols: Rheumatoid Arthritis (RA), Arthritis, and Arthrosis (Simple)

Sports Medicine, General Medicine, Rheumatologists, Traumatologists and Internists

RA is a chronic autoimmune disease (long-term) that causes pain, stiffness, swelling, and limited mobility and functioning of various joints. Although RA may affect any joint, the small joints of the hands and feet tend to be affected most often. Sometimes the disease can also affect organs, such as the eyes or lungs.

In general, the stiffness observed in active RA is frequently worse in the morning. It can last from one to two hours (or even all day). Stiffness over a prolonged period of time in the morning is a sign that you might have RA, since few other arthritic conditions share this symptom. For example, osteoarthritis does not tend to cause prolonged morning stiffness.
RA is an autoimmune disease.

This means that certain immune system cells begin to attack healthy tissue the joints in the case of RA. The cause of RA is unknown. However, new research is giving us a better idea of what makes the immune system attack the body and generate inflammation. In RA, the focus of the inflammation is found in the synovial membrane, the tissue covering the joint. Immune system cells release chemical substances that cause inflammation.
These chemical substances can cause damage to cartilage (the tissue that acts as a shock absorber between joints) and bones.

There are other factors which are also likely to contribute to RA. For example, the genes that relate to the immune system may cause some people to be more prone to suffer from RA.
Arthrosis or osteoarthritis (less commonly used in clinical practice) is a disease caused by the wear and tear on cartilage, the tissue that functions as a shock absorber by protecting the ends of bones to aid joint movement.

It is the most common rheumatic disease, especially among the elderly. It appears prematurely in individuals with genetic diseases affecting connective tissue, such as Ehlers-Danlos syndrome and articular hypermobility syndrome.

In arthrosis, the surface of the cartilage breaks down and wears out, which causes the bones to rub against one another and generate friction, pain, swelling and loss of movement in the joint. Over time, the joint loses its original shape and may develop spurs. In addition, pieces of bone and cartilage may break off and float around inside the joint space, which causes more pain and damage.

Arthrosis can affect any joint in the body. However, most common are arthrosis of the spine, which tends to affect the neck and the lower back (lumbar arthrosis); arthrosis of the hip and knee, and arthrosis of the hands, trapeziometacarpal joint (rhizarthrosis) and feet, which tends to appear after the age of 50.

Protocol 2 (Mild Arthritis and Prevention)

Cellorgane Multi-complex No. 4 Bones, Cartilages, Vertebrae. Oral

  • Cellorgane Multi-complex tablets. Take 2 tablets in the morning (on an empty stomach) and 2 tablets in the evening (on an empty stomach). Treatment should be taken continu-ously for at least 3 months, and then re-evaluate.

Protocol 3 (Severe Arthritis)


  • Bioenzym tablets, take 2 tablets in the morning (on an empty stomach) and 2 tablets at night (on an empty stomach). Treatment should be taken continuously for at least 3 months, and then re-evaluate.

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.


Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.


This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2021 Biocell Ultravital